Methenamine Prices

Methenamine Prices June 2024

The methenamine prices in the United States for Q2 2024 reached 850 USD/MT in June. The market conditions reflected diverse sectoral dynamics. The decline in the rubber sector impacted demand, whereas the pharmaceutical industry maintained positive demand because of its use as a urinary antiseptic. Shifts in feedstock costs, particularly formaldehyde and ammonia, added intricacy to the pricing environment. This combination of rising production expenses and varying sector-specific demand created a challenging landscape for market participants.

In Saudi Arabia, the methenamine prices for Q2 2024 reached 760 USD/MT in June. The market experienced continued price declines, influenced by lower demand and ample inventory. The region's core sectors, including pharmaceuticals, textiles, and polymers, saw reduced activity, resulting in bearish market sentiment. The anticipated increase in summer demand, which is typically robust, did not materialize, exacerbating the decline. Stable feedstock prices further prevented any upward push, solidifying the overall downward market trajectory.

Methenamine Prices December 2023

The price trend for methenamine in China for Q4 2023, reached 1025 USD/MT in December. At the close of Q4 2023, China's methenamine market faced falling prices due to weak demand and reduced export prices from Russia. With an oversupply situation, major suppliers maintained high inventory levels, leading to cautious production and minimal fresh bidding activities, reflecting subdued market sentiment and a strategic approach to managing existing stock.

The price trend for methenamine in Russia for Q4 2023, reached 820 USD/MT in December. By the end of Q4 2023, methenamine prices in Russia were declining due to a sluggish market with low export activity and increased stockpiles. Suppliers showed minimal engagement in inventory buildup, focusing instead on maintaining current levels. The broader market downturn led to restrained trading interest and limited fresh orders, indicating a cautious market approach.

Regional Coverage

The report provides a detailed analysis of the methenamine market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the methenamine price trend.

Global Methenamine Price

The report offers a holistic view of the global methenamine pricing trends in the form of methenamine price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights the current price but also provides insights into methenamine historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into methenamine price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed methenamine demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Methenamine Price

Q2 2024:

The European methenamine market navigated through a complex phase marked by varied trends across key sectors. The rubber sector experienced growth, which increased the use of methenamine as a vulcanization accelerator. Additionally, the pharmaceutical industry faced a downturn, leading to reduced demand where methenamine was utilized in urinary antiseptics. Costs for feedstock changed as formaldehyde and ammonia prices both decreased, potentially lowering production costs. Yet, this was counteracted by decreased demand for pharmaceuticals, resulting in a difficult market environment. The interplay between reduced feedstock prices and demand fluctuations required strategic management of inventory and pricing by market participants. This created a layered market environment that demanded careful navigation to balance production costs and sector-specific needs.

Q4 2023:

In Q4 2023, the Europe's methenamine market witnessed declining prices due to a slowing crude market, which impacted the cost of feedstocks such as formaldehyde and ammonia. The underperformance of the pharmaceutical and chemical sectors, both locally and in key importing markets such as China, exacerbated the challenges. Methenamine supply in Russia is limited due to reduced exports and increased stockpiles, which contributes to a downward price trend. Suppliers chose prompt replenishment over extensive accumulation, demonstrating a cautious market approach. The overall price decline was characterized by low trading interest and minimal demand, resulting in ongoing destocking by suppliers.

This analysis can be extended to include detailed methenamine price information for a comprehensive list of countries.

North America Methenamine Price

Q2 2024:

In the United States, the methenamine market faced complex challenges influenced by diverse industrial performance. The rubber sector downturn impacted demand negatively, while the pharmaceutical industry continued to support the market with stable demand owing to its use as a urinary antiseptic. Feedstock costs added another layer of complexity, with notable shifts in formaldehyde and ammonia prices. Formaldehyde's significant price inflation increased production expenses, while a reduction in ammonia prices partially balanced the cost pressures. This pricing volatility made a difficult scenario for market participants, who needed to stay vigilant in managing inventory and strategic pricing amid sector-specific trends and fluctuating feedstock prices. The balance between rising production expenses and varying sectoral demands contributed to an intricate market scenario for methenamine in the region.

Q4 2023:

By the end of Q4 2023, the methenamine market in the United States saw a significant price decline, driven by lowered costs of key feedstocks like formaldehyde and ammonia within the crude market. While the pharmaceutical sector performed well, overall demand from other sectors remained weak, prompting suppliers to reduce prices. With limited trading interest and subdued demand, suppliers focused on managing inventories efficiently through destocking activities. The PMI indicated a stagnant industrial environment, reflecting broader market challenges and production slowdowns, which influenced the price dynamics. As a result, methenamine prices trended downward, signaling caution among producers and distributors in the market.

Specific methenamine historical data within the United States and Canada can also be provided.

Middle East and Africa Methenamine Price

Q2 2024:

In the United States, the methenamine market faced complex challenges influenced by diverse industrial performance. The rubber sector downturn impacted demand negatively, while the pharmaceutical industry continued to support the market with stable demand owing to its use as a urinary antiseptic. Feedstock costs added another layer of complexity, with notable shifts in formaldehyde and ammonia prices. Formaldehyde's significant price inflation increased production expenses, while a reduction in ammonia prices partially balanced the cost pressures. This pricing volatility made a difficult scenario for market participants, who needed to stay vigilant in managing inventory and strategic pricing amid sector-specific trends and fluctuating feedstock prices. The balance between rising production expenses and varying sectoral demands contributed to an intricate market scenario for methenamine in the region.

Q4 2023:

The report explores the methenamine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on methenamine prices for countries can also be provided.

Asia Pacific Methenamine Price

Q2 2024:

In the second quarter of 2024, methenamine pricing in the Asia Pacific showed stability amidst various influencing factors impacting supply and demand. Seasonal shifts and market sentiment contributed to an overall stable environment, supported by well-maintained supply chains and balanced demand. Despite a notable long-term trend of price decline, recent quarterly adjustments pointed towards stabilization. In China, market movements were marked by periodic fluctuations, with significant impacts from seasonal demand in pharmaceuticals and food additives. The consistent end-of-quarter pricing reflected cautious optimism, buoyed by strong inventory and balanced supply-demand dynamics. This equilibrium, despite minor fluctuations, signaled a market without strong pressures driving prices up or down. The stable sentiment throughout the quarter indicated an outlook of steady market activity for methenamine in the region.

Q4 2023:

By late 2023, the China’s methenamine market was marked by falling prices, heavily influenced by reduced export pricing from Russia and a general drop in demand across key sectors like pharma, rubber, and polymer. Suppliers adjusted prices downward due to surplus inventory levels and subdued market sentiment. The supply of methenamine outstripped demand, leading to cautious production strategies and minimal fresh bidding activities. The surplus, combined with weak downstream consumption, led to price reductions and a careful approach to inventory management by suppliers. Overall, market activity remained subdued, with no significant uptick in fresh orders or inventory accumulation during the quarter.

This methenamine price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Methenamine Price

The analysis of methenamine prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Methenamine Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Methenamine Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2024 Edition,” offers an in-depth analysis of methenamine pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of methenamine at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of methenamine price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing methenamine price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Methenamine Market Analysis

The global methenamine market size reached 788.9 Thousand Tonnes in 2023. By 2032, IMARC Group expects the market to reach 1103.5 Thousand Tonnes, at a projected CAGR of 3.80% during 2023-2032.

• The increasing prevalence of urinary tract infections (UTIs) represents one of the key factors influencing the growth of the market across the globe. According to BMC, urinary tract infection (UTI) is one of the most common infectious diseases, second to upper respiratory tract infections. More than 50% of all women in at least 12% of men experience UTI in their lifetime. This is particularly significant in demographics with higher vulnerability to UTIs, like women, the elderly, and individuals with compromised immune systems which is driving the demand for effective antiseptic treatments such as methenamine. For instance, in December 2023, the US Food and Drug Administration (FDA) approved Lyrus Life Science’s Abbreviated New Drug Application (ANDA) for ‘Methenamine Hippurate Tablets USP, 1 gram.
• The rising aging population, along with a higher risk of chronic diseases and infections, such as UTIs among the geriatric population is boosting the market growth. According to the World Health Organization (WHO) by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050 the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
• The growing use of methenamine as a long-term preventive measure in elderly patients is driving the market growth. According to BMC, on logistic regression, elderly patients (>60 years) had five times higher odds of having UTI as compared to adolescents. Female participants had almost two times higher odds of having UTI as compared to male participants at the borderline p= 0.05.
• Methenamine presents a non-antibiotic alternative for managing and preventing urinary infections with increasing concerns regarding antibiotic resistance which is facilitating the growth of the market.

Methenamine News

The report covers the latest developments, updates, and trends impacting the global methenamine market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in methenamine production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the methenamine price trend.

Latest developments in the methenamine industry:

• In November 2023, Bayer announced new late-breaking Kerendia (finerenone) data from FIDELITY, a prespecified pooled analysis of the Phase III FIDELIO-DKD and FIGARO-DKD trials, confirming that early albuminuria reduction in patients with chronic kidney disease (CKD) in type 2 diabetes (T2D) mediated a large proportion of the treatment effect against CKD progression.
• In February 2024, Cipla Limited received approval from the Central Drug Standard Control Organization (CDSCO) to market the novel antibiotic Plazomicin in India. Plazomicin is the new intravenous (IV) aminoglycoside indicated for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis.

Product Description

Methenamine refers to a synthetic, heterocyclic organic compound employed majorly as a urinary antiseptic with the chemical formula C6H12N4.

Methenamine functions by decomposing into formaldehyde in acidic environments like the urine, where it acts to sterilize the urinary tract by killing bacteria. This makes it effective in the treatment and prevention of urinary tract infections (UTIs).

Methenamine is often administered in the form of salts, like methenamine Hippurate or methenamine mandelate, which are taken orally. These formulations help maintain an acidic pH in the urine, enhancing the drug’s effectiveness.

The use of methenamine is particularly beneficial in managing chronic urinary infections in institutions where long-term prophylactic treatment is required. It is generally well-tolerated, but it is not suitable for treating systematic infections as its action is localized to the urine. However, methenamine should not be employed by individuals with severe liver or kidney disease without medical supervision.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of methenamine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting methenamine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The methenamine price charts ensure our clients remain at the forefront of the industry.